Coronavirus Drug Discovery
Volume 2: Antiviral Agents from Natural Products and Nanotechnological Applications
- 1st Edition - July 12, 2022
- Editor: Chukwuebuka Egbuna
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 9 5 5 7 4 - 4
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 5 5 7 5 - 1
Coronavirus Drug Discovery, Volume Two: Antiviral Agents from Natural Products and Nanotechnological Applications presents detailed information on drug discovery against COVID-19.… Read more
Coronavirus Drug Discovery, Volume Two: Antiviral Agents from Natural Products and Nanotechnological Applications presents detailed information on drug discovery against COVID-19. Sections in this volume present chapters that focus on the various antiviral agents from natural products that have the propensity to be used as chemical scaffolds for the development of drugs against COVID-19. Also captured are the dietary sources of antioxidant bioactives that may help boost the immune system for the management of COVID-19. Other chapters describe the application of nanotechnology for efficient and effective delivery of drugs against COVID-19.
Written by global team of experts, this book is an excellent resource for drug developers, medicinal chemists, pharmaceutical companies in R&D and research institutes in both academia and industry.
- Presents the various antiviral bioactive compounds from natural products
- Discusses the roles of antioxidant in the prevention and management of COVID-19
- Details the application of nanotechnology for efficient and effective drug delivery
Researchers in organic and medicinal chemistry including drug developers and medicinal chemists, virologists, toxicologists, analytical chemists.Researchers in pharmaceutical and biotech industries
PART I: ANTIVIRAL AGENTS FROM NATURAL PRODUCTS
1. COVID-19 management and phytomedicine interventions: Potentials and safety considerations
2. Plants with potent antiviral properties
3. Antiviral effects of medicinal plants and their active phytochemical constituents against respiratory diseases and associated biological functions
4. Herbs and drugs in clinical trials for coronavirus treatments
5. Herbal-Based Resources against Exanthematous Viral Infections and Other Viral Diseases
6. Dietary polyphenols as therapeutic agents to combat COVID-19
7. Bioactive compounds and herbal preparations implicated in for the treatment of SARS-CoV-2
8. Roles of Antioxidants in the Prevention and Management of Coronavirus Disease 2019
9. Food sources of natural antioxidants for body defence against SARS-CoV-2
10. Nutritional Management against Severe Acute Respiratory Syndrome Coronavirus-2 Infection
- Edition: 1
- Published: July 12, 2022
- Language: English
CE
Chukwuebuka Egbuna
Chukwuebuka Egbuna (PhD) is a chartered chemist and academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), and the Royal Society of Chemistry (RSC) (United Kingdom). Dr. Egbuna is the founder and editor of the Elsevier book series on Drug Discovery Update. The series includes books, monographs, and edited collections from all areas of drug discovery including emerging therapeutic claims for the treatment of diseases. He has published research articles in many international journals of repute and is ranked among the top 500 Nigerian scientists in SciVal/SCOPUS. He has edited more than 25 books with Elsevier, Springer, Wiley, and Taylor & Francis. His most recent book is the three volume Coronavirus Drug Discovery, published by Elsevier. Dr. Egbuna is the founder and the publishing director of IPS Intelligentsia Publishing Services.
Affiliations and expertise
Africa Centre of Excellence in Public Health and Toxicological Research, University of Port Harcourt, NigeriaRead Coronavirus Drug Discovery on ScienceDirect